Breaking News: Shaping the future of AMD and DME

Track:
Co-Developed Symposium
What:
Co-Developed Symposium | Symposium élaboré conjointement
When:
6:30 AM, Sunday 12 Jun 2022 (1 hour 30 minutes)
Breaks:
Continental Breakfast    07:00 AM to 08:00 AM (1 hour)
How:

LEARNING OBJECTIVES

At the end of this symposium, participants will be able to:

  • Identify the critical unmet needs in neovascular AMD and DME management
  • Demonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME management
  • Examine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DME
  • Apply new insights from multi-modal imaging platforms to optimize diagnosis and management in the retina clinic

CanMEDS Roles: Medical Expert, Scholar

SCIENTIFIC PLANNING COMMITTEE
Varun Chaudhary, MD, Chair
Arif Samad, MD
Sarah Mullen, MD
 

This symposium was co-developed with the Canadian Ophthalmological Society and Roche, in order to achieve scientific integrity, objectivity and balance.

Moderator
2022 Planning Committee - Retina
Keynote speaker
Keynote Speaker
Speaker
Keynote Speaker | Conférencier Invité

Sub Sessions

Talk | Exposé
RetinaCo-Developed Symposium
Moderator Varun Chaudhary | Panelist Sunir Garg | Panelist Wai-Ching Lam | Panelist Michael Ip
Panel | Table ronde
RetinaCo-Developed Symposium
Speaker Michael Ip
RetinaCo-Developed Symposium
Panelist Michael Ip | Panelist Sunir Garg | Panelist Wai-Ching Lam | Moderator Varun Chaudhary
RetinaCo-Developed Symposium
Panelist Wai-Ching Lam | Panelist Michael Ip | Panelist Sunir Garg | Moderator Varun Chaudhary
RetinaCo-Developed Symposium
Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.